The global tumor ablation market is expected to grow from USD 0.8 billion in 2024 to USD 1.4 billion by 2029, expanding at a CAGR of 10.0% over the forecast period. This substantial growth is driven by technological advancements, new product developments—particularly in cryoablation—and the rising incidence of cancer worldwide. As a minimally invasive treatment option, tumor...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Italiano
Russian
Romaian